Procedures are facilitated for marketing of domestically produced foreign pharmaceuticals
May 17, 2024
Procedures are facilitated for marketing of domestically produced foreign pharmaceuticals
Business operators may not set different charge rates for the same good or service
SAMR specifies details on collecting electronic evidence
CSRC intensifies IPO random inspection
China lifts foreign investment restrictions on value-added telecommunications services
Shenzhen expands the scope of PE investments
Measures are laid out for handling of sensitive data by banking and insurance institutions
A data transfer path is required for transferring natural resources data
The carrying out of specialized subcontracting of road works is encouraged